CARTIHEAL THE FUTURE OF JOINT REPAIR
LIVE

Serial Number

79270317

Owner

CARTIHEAL (2009) LTD.

Attorney

John L. Strand

Filing Date

Jul 22, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CARTIHEAL THE FUTURE OF JOINT REPAIR Trademark

Serial Number: 79270317 • Registration: 6115540

CARTIHEAL THE FUTURE OF JOINT REPAIR is a trademark filed by CARTIHEAL (2009) LTD. on July 22, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CARTIHEAL (2009) LTD. (13 trademarks)

17 Atir Yeda Street

Entity Type: 99

Trademark Details

Filing Date

July 22, 2019

Registration Date

August 4, 2020

Published for Opposition

May 19, 2020

Goods & Services

Pharmaceutical preparations and substances for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, bone, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders; veterinary preparations and substances for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, bone, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders; medicines for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, bone, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders; pharmaceutical preparations and medicines for preventing transplant rejection; chemical, biochemical and biological substances for medical and veterinary purposes, namely, body and cartilage implants comprising living tissue; sanitary preparations for medical purposes; food for babies; dietary supplements for humans and animals; nutritional supplements, vitamins, mineral supplements; medical plasters, materials for dressings, namely, gauze; medical adhesive tape, namely, dissolvable strips to stop bleeding from minor cuts and grazes; material for stopping teeth, dental wax; disinfectants for hygienic purposes; chemical preparations for pharmaceutical purposes, namely, for genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, bone, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders; diagnostic preparations for medical use; diagnostic reagents for medicinal use; preparations for destroying vermin; fungicides, herbicides

Retail and wholesale services, namely, retail and wholesale stores featuring pharmaceutical preparations, medicines, medical, surgical and dental apparatus and instruments, nutritional supplements, vitamins, mineral supplements; advertising and business management services; business management; providing office functions; import agencies; sales promotion services; business consulting services; business information services; public relations services; electronic commerce services, namely, providing information about products via telecommunication networks for advertising and sales purposes; procuring of contracts for purchase of advertising space; rental of advertising space; direct mail advertising; business networking; arranging of business introductions; conducting of exhibitions for business purposes

Surgical apparatus and instruments; medical, dental and veterinary apparatus and instruments for use in transplantation; artificial limbs, eyes and teeth; orthopedic articles, namely, braces, joint implants made from artificial materials, shoe inserts, wrist, neck, back, ankle, knee and elbow supports and splints; bone, joint, ankle, knee, elbow, leg and hand prostheses; surgical implants comprised of artificial materials; medical implants, namely, bone and cartilage implants comprised of artificial materials; spinal implants comprised of artificial materials; suture materials; replacement parts for the aforementioned goods

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 4, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Mar 30, 2024 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 27, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 27, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 27, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 27, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 27, 2024 COAR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 20, 2022 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Aug 21, 2022 RHRD
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 12, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 25, 2020 FICS
FINAL DISPOSITION PROCESSED
Nov 25, 2020 FIMP
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Nov 25, 2020 CORN
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 4, 2020 FICR
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 1, 2020 CRCV
REGISTERED-PRINCIPAL REGISTER
Aug 4, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 14, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 14, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 14, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 14, 2020 CNEA
DATA MODIFICATION COMPLETED
Apr 10, 2020 DMCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2020 CRFA
ASSIGNED TO LIE
Apr 9, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2020 TROA
REFUSAL PROCESSED BY IB
Dec 14, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 23, 2019 RFCS
REFUSAL PROCESSED BY MPU
Nov 22, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 2, 2019 RFCR
APPLICATION FILING RECEIPT MAILED
Nov 2, 2019 MAFR
NON-FINAL ACTION WRITTEN
Nov 1, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 29, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 29, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 24, 2019 REPR